Association of unbalanced translocation der(1;7) with germline GATA2 mutations
-
- Emilia J. Kozyra
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Gudrun Göhring
- Department of Human Genetics, Hannover Medical School, Hannover, Germany;
-
- Dennis D. Hickstein
- Immune Deficiency–Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD;
-
- Katherine R. Calvo
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD;
-
- Courtney D. DiNardo
- Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
-
- Michael Dworzak
- St. Anna Childreńs Hospital and Cancer Research Institute, Pediatric Clinic, Medical University of Vienna, Vienna, Austria;
-
- Valerie de Haas
- Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands;
-
- Jan Starý
- Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic;
-
- Henrik Hasle
- Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark;
-
- Akiko Shimamura
- Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA;
-
- Mark D. Fleming
- Department of Pathology, Boston Children's Hospital, Boston, MA;
-
- Hiroto Inaba
- Department of Oncology and
-
- Sara Lewis
- Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN;
-
- Amy P. Hsu
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;
-
- Steven M. Holland
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;
-
- Danielle E. Arnold
- Immune Deficiency–Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD;
-
- Cristina Mecucci
- Department of Medicine, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy;
-
- Siobán B. Keel
- Department of Medicine, Division of Hematology, University of Washington, Seattle, WA;
-
- Alison A. Bertuch
- Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX;
-
- Kiran Tawana
- Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom;
-
- Shlomit Barzilai
- Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel;
-
- Shinsuke Hirabayashi
- Department of Pediatrics and
-
- Masahiro Onozawa
- Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan;
-
- Shaohua Lei
- Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN;
-
- Helena Alaiz
- Hematology Department, Oncology Institute Francisco Gentil, Lisbon, Portugal;
-
- Hajnalka Andrikovics
- Laboratory of Molecular Diagnostics, Central Hospital of Southern Pest, Budapest, Hungary;
-
- David Betts
- National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland;
-
- Berna H. Beverloo
- Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands;
-
- Jochen Buechner
- Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway;
-
- Martin Čermák
- Department of Genetics, The National Institute of Oncology, Bratislava, Slovakia;
-
- José Cervera
- Department of Hematology, Genetics Unit, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Hospital Universitario y Politécnico La Fe, Valencia, Spain;
-
- Olga Haus
- Department of Clinical Genetics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland;
-
- Kirsi Jahnukainen
- New Children's Hospital, Pediatric Research Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;
-
- Kalliopi N. Manola
- Department of Biodiagnostic Sciences and Technologies, The Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES), National Centre for Research 'Demokritos', Athens, Greece;
-
- Karin Nebral
- Labdia Labordiagnostik GmbH, Clinical Genetics, Vienna, Austria;
-
- Francesco Pasquali
- Medical Genetics, Department of Medicine and Surgery, University of Insubria, Varese, Italy;
-
- Joelle Tchinda
- Laboratory for Oncology, University Children's Hospital Zürich, Zürich, Switzerland;
-
- Dominik Turkiewicz
- Department of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden;
-
- Nadine Van Roy
- Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;
-
- Zuzana Zemanova
- Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine of Charles University, Prague, Czech Republic; and
-
- Victor B. Pastor
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Brigitte Strahm
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Peter Noellke
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Charlotte M. Niemeyer
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Brigitte Schlegelberger
- Department of Human Genetics, Hannover Medical School, Hannover, Germany;
-
- Ayami Yoshimi
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
-
- Marcin W. Wlodarski
- Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
この論文をさがす
収録刊行物
-
- Blood
-
Blood 138 (23), 2441-2445, 2021-12-09
American Society of Hematology
- Tweet
キーワード
- Adult
- Male
- HIGH-FREQUENCY
- Adolescent
- 610
- FAMILIAL MYELODYSPLASTIC SYNDROME
- Middle Aged
- Translocation, Genetic
- DEFICIENCY
- GATA2 Transcription Factor
- Young Adult
- Myelodysplastic Syndromes
- Humans
- Female
- Child
- Myelodysplastic Syndromes/genetics
- FAMILIAL MYELODYSPLASTIC SYNDROME; HIGH-FREQUENCY; DEFICIENCY
- Germ-Line Mutation
- GATA2 Transcription Factor/deficiency
詳細情報 詳細情報について
-
- CRID
- 1360576118835602688
-
- ISSN
- 15280020
- 00064971
-
- HANDLE
- 11391/1502563
-
- PubMed
- 34469508
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE
